5901 - 5910 of 8587 Results
Title
Year
-
OPENTitle: New insights from a Malaysian real-world deep brain stimulation cohortJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x241297715Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1877718X241297715Citation Count: 0
- Tissue transglutaminase in Alzheimer's disease – facts and fiction: a reply to “Tissue transglutaminase is a biochemical marker for Alzheimer's disease”2013RESTRICTEDTitle: Tissue transglutaminase in Alzheimer's disease – facts and fiction: a reply to “Tissue transglutaminase is a biochemical marker for Alzheimer's disease”Journal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 4Start Page: e5End Page: e9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.09.042Citation Count: 14
- Validation of a data-driven motion-compensated PET brain image reconstruction algorithm in clinical patients using four radiotracers2025OPENTitle: Validation of a data-driven motion-compensated PET brain image reconstruction algorithm in clinical patients using four radiotracersJournal Name: EJNMMI PhysicsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s40658-025-00723-wBest OA location URL: https://link.springer.com/content/pdf/10.1186/s40658-025-00723-w.pdfCitation Count: 0
-
OPENTitle: Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson′s DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1761End Page: 1767Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29124Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29124Citation Count: 7
- CRISPR/Cas9‐Based Functional Genomics in Human Induced Pluripotent Stem Cell–Derived Models: Can “the Stars Align” for Neurodegenerative Diseases?2022RESTRICTEDTitle: CRISPR/Cas9‐Based Functional Genomics in Human Induced Pluripotent Stem Cell–Derived Models: Can “the Stars Align” for Neurodegenerative Diseases?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 886End Page: 890Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28998Citation Count: 1
-
OPENTitle: Amygdala Neurodegeneration: A Key Driver of Visual Dysfunction in Parkinson's DiseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 12Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.70007Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.70007Citation Count: 1
- Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases2013OPENTitle: Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic casesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 58Issue #:Start Page: 183End Page: 190Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2013.05.017Best OA location URL: http://infoscience.epfl.ch/record/189244Citation Count: 48
- IntranasalNAP(davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α‐synuclein2014OPENTitle: IntranasalNAP(davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α‐synucleinJournal Name: Pharmacology Research & PerspectivesPublisher: WileyVol: 2Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/prp2.65Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.65Citation Count: 43
- 4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both In vitro and In vivo Models of Parkinson's Disease2017OPENTitle: 4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both In vitro and In vivo Models of Parkinson's DiseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2017.00272Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2017.00272/pdfCitation Count: 19
- Dopaminergic Axon Tracts Within a Hyaluronic Acid Hydrogel Encasement to Restore the Nigrostriatal Pathway2024OPENTitle: Dopaminergic Axon Tracts Within a Hyaluronic Acid Hydrogel Encasement to Restore the Nigrostriatal PathwayJournal Name: Advanced Healthcare MaterialsPublisher: WileyVol: 14Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/adhm.202402997Best OA location URL: https://onlinelibrary.wiley.com/doi/am-pdf/10.1002/adhm.202402997Citation Count: 3